GERN

Conviction 8HealthcareScan · Thu, Sep 24, 2026

Geron Corp (GERN) closed at $1.25 (+0.81%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 36, RS Rating 28, -35.9% from its 52-week high, -5.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

GERN$1.25+0.81%

ResistanceSupportVol 14

Vol MA14 10.38M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

GERON CORPPHARMACEUTICAL PREPARATIONSwww.geron.com ↗

Price1.25

Change+0.81%

Gap-0.81%

Rel volume0.79×

Avg volume10.84M

Avg $ vol15.29M

SMA 201.40

SMA 501.45

SMA 2001.45

Price vs 50-13.54%

Price vs 200-13.64%

MA stackbearish

50/200 crossdeath · 0d

Supertrenddown · 1.44

RSI (14)36

MACD hist-0.02

MACD cross—

Stoch %K / %D13 / 10

ADX (14)21

+DI / −DI13 / 30

RSI divergence—

MACD divergenceBearish

ATR %5.82%

ADR %4.94%

52w high1.95

52w low1.07

From 52w high-35.90%

Above 52w low+16.82%

New 52w highNo

SqueezeOff

Bollinger width31.29%

%B0.16

Donchian pos11.90%

Donchian high1.62

Donchian low1.20

AVWAP (52w high)1.49

vs AVWAP high-16.10%

AVWAP (52w low)1.46

vs AVWAP low-14.39%

OBV trendDown

Chaikin MF (20)-0.14

Today vs 20d0.79×

Avg vol (14d)10.38M

Avg vol (20d)10.84M

Avg $ vol (20d)15.29M

Market cap803.09M

RS Rating28 / 99

RS 3m (vs SPY)-13.25%

RS 6m (vs SPY)-37.20%

RS line new highNo

Trend template2/8

Technical rank17.0

1 week-5.30%

1 month-19.35%

3 months-8.76%

6 months-20.38%

1 year-6.72%

YTD-5.30%

P/E-9.62

P/B3.67

P/S—

P/FCF-7.19

EPS-0.1300

Div yield—

ROE-38.20%

ROA-16.09%

Debt/Eq0.88

Current6.92

EV/EBITDA-13.69

Gross margin—

Net margin—

Rev growth-60.23%

EPS growth52.17%

Price target4.33

Target upside246.40%

Analyst ratingBuy

Institutional80.11%

Ent. value932.14M

Revenue57.48M

Net income-16.68M

Gross profit—

Free cash flow-111.72M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out641.52M

Employees258

ListedWed, Jul 31, 1996

Free float625.8M

Float %97.6%

Short interest85.09M

Days to cover11.0d

Short volume49.6%

Squeeze score59 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.02 vs −$0.01

Last surprise-100.0% miss

Setup gradeD

Conviction8 / 100

Pattern quality—

Tech rank17.0 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.64

Support1.35

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GERN

All disclosures →

No recent disclosed trades by Congress in GERN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GERN

Insider	Side	Shares	Value	Traded	Filed
Bir Dawn Carter Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
O'Farrell Elizabeth G. Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
Molineaux Susan Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
Spiegel Robert J. Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
McDonald John F Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
Williams Timothy EVP and Chief Legal Officer · Stock Option (Right to Buy) · 2026-04-13	Grant	2.5M	$0	2026-04-13	2026-04-14

SEC filings

EDGAR filings in GERN · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.